# Eli Lilly & Company – FDA Inspection, Sep 3, 2010

Source: https://www.keypedia.com/records/fda_inspections/eli-lilly-company/2d8d37c6-ee02-4cd6-82fd-a127e22652ea
Source feed: FDA_Inspections

> FDA inspection 682301 of Eli Lilly & Company, September 03, 2010. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 314 and 600. 35 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 682301
- Company Name: Eli Lilly & Company
- Inspection Date: 2010-09-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1298628 - 2026-01-09
- [FDA Inspection 1270621 - 2025-05-20](https://www.keypedia.com/records/fda_inspections/eli-lilly-company/809cae3e-94ad-47cf-a116-8f4799dc570f)
- FDA Inspection 1260339 - 2025-03-27
- FDA Inspection 1229895 - 2025-01-15
- [FDA Inspection 1220489 - 2023-10-06](https://www.keypedia.com/records/fda_inspections/eli-lilly-company/4c2819f7-b6f3-4b07-998f-0338105e6e0b)

Company: https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c